COVID-19와 같은 전염병 감염 시나리오 전반에 걸쳐 펩타이드 기반 치료법을 발견하고 설계하는 개발 시대의 추세는 보다 효율적이고 저렴한 치료 환경으로 발전할 수 있습니다. 결과적으로, 그들의 단백질 분해 약화는 천연 펩타이드 약물의 단점 중 하나입니다. 펩티도미메틱스는 이 단점을 해결하는 데 도움이 될 수 있습니다. 이 리뷰에서 펩타이드 및 펩타이드 기반 약물 발견은 숙주 안지 오텐신 전환 효소-2(ACE2) 수용체 및 바이러스 스파이크 (S)단백질의 연관성을 포함하는 중증 코로나바이러스 폐색전 증후군(SARS-CoV-2)의 주요 진입 기전 중 하나를 표적으로 요약했습니다. 또한, 펩타이드 기반의 새로운 치료법을 통해 COVID-19에 대해 연구된 단백질, 펩타이드 및 기타 가능한 조치의 이점을 다룹니다. 그리고 펩타이드 기반 약물 치료 환경의 개요는 진화적 관점, 구조적 특성, 작동 한계값 및 치료 영역에 대한 설명으로 구성된다

Trends in the developing era to discover and design peptide-based treatments throughout an epidemic infection scenario such as COVID-19 could progress into a more efficient and low-cost therapeutic environment. However, the weakening of proteolysis is one downside of natural peptide drugs. But, peptidomimetics may help resolve this issue. In this review, peptide and peptide-based drug discovery were summarized to target one key entry mechanism of severe coronavirus pulmonary emboli syndrome (SARS-CoV-2), which encompasses the association of the host angiotensin-converting enzyme-2 (ACE2) receptor and viral spike (S) protein. Furthermore, the benefits of proteins, peptides and other possible actions that have been studied for COVID-19 through new peptide-based treatments are discussed in the review. Lastly, an overview of the peptide-based drug therapy environment is comprised of an evolutionary viewpoint, structural properties, operational thresholds, and an explanation of the therapeutic area.

ABSTRACT
Mechanism of COVID viral infection
The invention of peptide therapy
Peptide target on the spike (s) glycoprotein
Peptide targeting towards inhibition ofendosomal/lysosomal acidification
Host defense mechanism: protecting thereceptor of the cell
Immunomodulatory based antiviral therapy
Antiviral peptide therapy’stowards future directions
Conclusion
Supplementary Materials
국문요약
References

• Ramachandran Chelliah(Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University)
• Eric Banan-Mwine Daliri(Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University)
• Fazle Elahi(Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University)
• Su-Jung Yeon(Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University)
• Akanksha Tyagi(Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University)
• Chae Rin Park(Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University)
• Eun Ji Kim(Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University)
• Jo kyoung Hee(Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University)
• Deog-Hwan Oh(Department of Food Science and Biotechnology, College of Agriculture and Life Science, Kangwon National University) Correspondence to